These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 7936476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of amlodipine and captopril on clinic and ambulatory blood pressure.
    Lacourcière Y, Poirier L, Provencher P.
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S25-8. PubMed ID: 1293305
    [Abstract] [Full Text] [Related]

  • 5. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A, Dunne B, Glazer N, Kostis JB, Miller WE, Rector DJ, Tresznewsky ON.
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of the antihypertensive efficacy of lisinopril and captopril associated with hydrochlorothiazide by ambulatory measurement of arterial pressure].
    Vaïsse B, Renucci JF, Delage Y, Madonna O, Gressin V, Poggi L.
    Ann Cardiol Angeiol (Paris); 1993 Dec; 42(10):566-72. PubMed ID: 8117053
    [Abstract] [Full Text] [Related]

  • 7. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring.
    Lacourcière Y, Poirier L, Provencher P.
    J Cardiovasc Pharmacol; 1993 Dec; 22 Suppl A():S20-3. PubMed ID: 7522283
    [Abstract] [Full Text] [Related]

  • 8. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 9. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 10. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 11. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J.
    Arch Inst Cardiol Mex; 1997 Feb; 67(1):29-37. PubMed ID: 9221708
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
    Weir MR, Fagan T, Chrysant S, Flamenbaum W, Kaihlanen PM, Lueg M, Anzalone D.
    J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
    [Abstract] [Full Text] [Related]

  • 13. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
    Beltman FW, Heesen WF, Smit AJ, May JF, de Graeff PA, Havinga TK, Schuurman FH, van der Veur E, Lie KI, Meyboom-de Jong B.
    Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L, Hidas I, Iványi J, Dudás M, Molnár S.
    Orv Hetil; 1996 Dec 22; 137(51):2851-4. PubMed ID: 9679620
    [Abstract] [Full Text] [Related]

  • 15. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ, Ramsay LE, Hettiarachchi J.
    Clin Pharmacol Ther; 1998 Oct 22; 64(4):439-49. PubMed ID: 9797801
    [Abstract] [Full Text] [Related]

  • 16. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressures.
    Whelton A, Miller WE, Dunne B, Hait HI, Tresznewsky ON.
    J Clin Pharmacol; 1990 Dec 22; 30(12):1074-80. PubMed ID: 2177062
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, parallel comparative study of the antihypertensive efficacy of once-daily lisinopril vs enalapril with 24-h ambulatory blood pressure monitoring in essential hypertension.
    Coca A, Sobrino J, Módol J, Soler J, Mínguez A, Plana J, De la Sierra A.
    J Hum Hypertens; 1996 Dec 22; 10(12):837-41. PubMed ID: 9140792
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination and captopril 50 mg/hydrochlorothiazide 25 mg fixed combination].
    Milon H, Baleydier A.
    Therapie; 1997 Dec 22; 52(3):195-205. PubMed ID: 9366103
    [Abstract] [Full Text] [Related]

  • 19. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B, Burnier M, Nussberger J, Lecomte JM, Brouard R, Waeber B, Brunner HR.
    J Hypertens; 1995 Jul 22; 13(7):797-804. PubMed ID: 7594444
    [Abstract] [Full Text] [Related]

  • 20. Once-daily monotherapy with trandolapril in the treatment of hypertension.
    Smith DH, Neutel JM, Black HR, Schoenberger JA, Weber MA.
    J Hum Hypertens; 1996 Feb 22; 10(2):129-34. PubMed ID: 8867568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.